Candidate-gene data indicate that APOE polymorphisms modulate risk in both conditions: ε2 and ε4 have been reported to increase psoriasis susceptibility (with ε3 protective), mirroring ε4-driven AD risk and suggesting allele-specific effects on lipid handling, vascular integrity, and inflammation. Here, APOE is linked to psoriasis.